enteric-coated aspirin

Also found in: Dictionary.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Words related to enteric-coated aspirin

aspirin that is treated to pass through the stomach unaltered and to dissolve in the intestines

References in periodicals archive ?
The findings by Bhatt et al suggest enteric-coated aspirin may be less effective at treating blood clots.
The FDA approval of YOSPRALA was based on the results from two randomised, double-blind controlled clinical trials that patients were randomly assigned to receive either YOSPRALA 325 mg/40 mg (n=524) or 325 mg of enteric-coated aspirin (n=525).
Study participants were randomized to conventional enteric-coated aspirin at 325 mg/day or to the investigational tablet, known for now as PA32540.
With repeated exposure, individuals categorized as nonresponders when given enteric-coated aspirin showed evidence of responses when administered immediate-release aspirin.
Gastrointestinal blood loss with low dose (325 mg) plain and enteric-coated aspirin administration.
Enteric-coated aspirin is usually labeled "safety coated" or "safer on the stomach.
Although some trials have used enteric-coated aspirin for initial dosing, more rapid buccal absorption occurs with non-enteric-coated formulations (AHA, 2004).
enteric-coated aspirin to prevent stroke after vertebral artery injury
Patients using enteric-coated aspirin also were more likely than others to show resistance.
In a 2 1/2-year study of 517 people who had been cured of colorectal cancer, a new polyp was found in 17 percent of those taking a daily enteric-coated aspirin (325 mg), compared to 27 percent of those taking a placebo.
The ADA recommends daily enteric-coated aspirin for diabetic patients who already have evidence of cardiovascular disease and for those without CVD who have one or more risk factors for the disease, Ms.
Enteric-coated aspirin (ECASA) is another very safe and much cheaper alternative to acetaminophen and much less expensive than the NSAIDs or the non-acetyl salicylates.
When enteric-coated aspirin is involved, proper absorption may be delayed and the level of overdosage may not be apparent.
Subjects were randomly assigned to once-daily treatment with PA32540 or 325 mg of enteric-coated aspirin.